A phase I study of fluzoparib tablet formulation, an oral PARP inhibitor: effect of food on the pharmacokinetics and metabolism after oral dosing in healthy Chinese volunteers

2021 ◽  
pp. 1-6
Author(s):  
Min Wu ◽  
Xiaojiao Li ◽  
Jixuan Sun ◽  
Hong Chen ◽  
Yanhua Ding
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Parp Inhibitor ◽  
Tablet Formulation ◽  
Oral Dosing ◽  
Effect Of Food ◽  
Healthy Chinese

scholarly journals Phase I study of propiverine hydrochloride. The 2nd Report. Repeated oral dosing study.

1990 ◽  
Vol 21 (3) ◽  
pp. 567-578 ◽  
Author(s):  
Kazuo HANAOKA ◽  
Toyoki KUGIMIYA ◽  
Yutaka INADA ◽  
Yoshio YAMAMOTO ◽  
Teruyoshi MARUNAKA ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Oral Dosing

Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours

2015 ◽  
Vol 76 (4) ◽  
pp. 723-729 ◽  
Author(s):  
Ruth Plummer ◽  
Helen Swaisland ◽  
Karin Leunen ◽  
Carla M. L. van Herpen ◽  
Guy Jerusalem ◽  
...  
Keyword(s):  
Tablet Formulation ◽  
Solid Tumours ◽  
Oral Dosing ◽  
Effect Of Food

scholarly journals Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C

2010 ◽  
Vol 50 (4) ◽  
pp. 434-449 ◽  
Author(s):  
Roy L. Hawke ◽  
Sarah J. Schrieber ◽  
Tedi A. Soule ◽  
Zhiming Wen ◽  
Philip C. Smith ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Phase I ◽  
Chronic Hepatitis C ◽  
Phase I Study ◽  
Oral Dosing
Sign in / Sign up

Export Citation Format

Share Document